| ( inverted question mark)-Verapamil hydrochloride |
| (??)-Verapamil hydrochloride |
| (?)-Verapamil hydrochloride |
| (+-)-5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile monohydrochloride |
| (+-)-Verapamil hydrochloride |
| (+/-)-VERAPAMIL HYDROCHLORIDE |
| (+/-)-Verapamil hydrochloride, >=99% (titration), powder |
| (+/-)-Verapamil hydrochloride, pharmaceutical secondary standard; traceable to USP and PhEur |
| (+/-)-Verapamil, Hydrochloride |
| (S)-(-)-Verapamil Hydrochloride |
| (y)-Verapamil hydrochloride |
| 152-11-4 |
| 152V114 |
| 2-(3,4-dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]-2-isopropylpentanenitrile hydrochloride |
| 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile hydrochloride |
| 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-propan-2-yl-pentanenitrile hydrochloride |
| 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile hydrochloride |
| 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile;hydrochloride |
| 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile hydrochloride |
| 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-isopropylpentanenitrile hydrochloride |
| 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl]methylamino}-2-(methy lethyl)pentanenitrile, chloride |
| 23313-68-0 |
| 36622-29-4 |
| 38176-10-2 |
| 5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrile hydrochloride |
| 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile monohydrochloride |
| 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile Hydrochloride |
| 54236-EP2305219A1 |
| 54236-EP2308562A2 |
| A816666 |
| AB0018370 |
| AC-16228 |
| AC-8483 |
| AC1L1Y4V |
| AC1Q3CE8 |
| Akilen |
| AKOS005267117 |
| AN-7969 |
| Anpec |
| API0024301 |
| Apo-Verap |
| ARONIS24174 |
| Arpamyl LP |
| AS-16018 |
| BBC/320 |
| BC210130 |
| Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride |
| Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride, (+-)- |
| Benzeneacetonitrile,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-.alpha.-(1-methylethyl)-, monohydrochloride |
| Berkatens |
| BG0353 |
| BIV1326 |
| C27H38N2O4.HCl |
| C27H39ClN2O4 |
| Calan (TN) |
| Calaptin |
| Calaptin 240 SR |
| Calcan hydrochloride |
| Cardiabeltin |
| Cardiagutt |
| Cardibeltin |
| Cardioprotect |
| CAS-152-11-4 |
| Caveril |
| CC-35585 |
| CCG-39491 |
| CHEMBL1280 |
| Civicor |
| Civicor Retard |
| Coraver |
| Cordilox SR |
| Corpamil |
| Covera |
| Covera-HS |
| Covera-hs (TN) |
| CS-1685 |
| D-365 hydrochloride |
| D00619 |
| Dignover |
| Dilacoran HTA |
| DOQPXTMNIUCOSY-UHFFFAOYSA-N |
| DSSTox_CID_14095 |
| DSSTox_GSID_34095 |
| DSSTox_RID_79114 |
| DTXSID2034095 |
| Durasoptin |
| EINECS 205-800-5 |
| Elthon |
| EN300-124002 |
| EU-0101237 |
| Flamon |
| FT-0603360 |
| FT-0655647 |
| Geangin |
| Harteze |
| Hexasoptin |
| Hexasoptin Retard |
| HMS1568M04 |
| HMS1922J16 |
| Hormitol |
| HSDB 3928 |
| HY-A0064 |
| I06-0615 |
| Ikacor |
| Ikapress |
| IN1425 |
| Inselon |
| Iproveratril hydrochloride |
| Isoptin Retard |
| Isoptin SR |
| Isoptino |
| Isotopin hydrochloride |
| Izoptin |
| Jenapamil |
| K-4825 |
| Lekoptin |
| Lodixal |
| LP01237 |
| LS-161199 |
| LU 20175 |
| Magotiron |
| Manidon |
| Manidon Retard |
| MFCD00055208 |
| MLS000069485 |
| MLS001055442 |
| MLS002222213 |
| MolPort-002-915-466 |
| NCGC00024710-03 |
| NCGC00094479-01 |
| NCGC00094479-02 |
| NCGC00094479-03 |
| NCGC00094479-04 |
| NCGC00094479-05 |
| NCGC00258732-01 |
| NCGC00261922-01 |
| Novapamyl LP |
| Novo-Veramil |
| NSC 135784 |
| NSC 272366 |
| NSC-272366 |
| NSC-657799 |
| NSC-759589 |
| NSC272366 |
| NSC657799 |
| NSC759589 |
| Nu-Verap |
| Opera_ID_1210 |
| OR075078 |
| OR245357 |
| Ormil |
| Pharmakon1600-02300307 |
| Praecicor |
| Prestwick_440 |
| Q-201923 |
| Quasar |
| R(+)-VERAPAMIL |
| R853 |
| Rapam |
| Robatelan |
| s4202 |
| SC-18887 |
| SCHEMBL33296 |
| SMR000059109 |
| SPECTRUM2300307 |
| ST066908 |
| ST24050346 |
| Tox21_201180 |
| Tox21_501237 |
| Univex |
| V 4629 |
| Valeronitrile, 5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropyl-, monohydrochloride |
| Valeronitrile, 5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropyl-,monohydrochloride |
| Vasolan (TN) |
| Vasomil |
| Vasopten |
| Vera-Sanorania |
| VERA? HYDROCHLORIDE |
| Verabeta |
| Veracaps SR |
| Veracor |
| Verahexal |
| Veraloc |
| Veramex |
| Veramil |
| Verapamil (hydrochloride) |
| Verapamil Acis |
| Verapamil AL |
| Verapamil Atid |
| Verapamil Basics |
| Verapamil chloridrate |
| Verapamil Ebewe |
| Verapamil HCl |
| Verapamil Henning |
| Verapamil hydrochloride |
| Verapamil Hydrochloride (Isoptin, Iproveratril, Calan) |
| Verapamil hydrochloride (JP17/USP) |
| Verapamil hydrochloride [USAN:JAN] |
| Verapamil hydrochloride [USAN:USP:JAN] |
| Verapamil Hydrochloride 1.0 mg/ml in Methanol (as free base) |
| Verapamil hydrochloride, European Pharmacopoeia (EP) Reference Standard |
| Verapamil hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| Verapamil Injection |
| Verapamil MSD |
| Verapamil NM |
| Verapamil NM Pharma |
| Verapamil Nordic |
| Verapamil PB |
| Verapamil Riker |
| Verapamil SR |
| Verapamil Verla |
| Verapamil-AbZ |
| VERAPAMILHYDROCHLORIDE |
| Verapamyl hydrochloride |
| Verapin |
| Verapress 240 SR |
| Verasal |
| Verasifar |
| Veratensin |
| Verdilac |
| Verelan (TN) |
| Verelan SR |
| Veroptinstada |
| Verpamil |
| Vetrimil |
| Vortac |
| Z2210978706 |
| ZX-AFC000544 |
| ZX-AS004533 |
